# US 2023/0389959 A1 · Methods and Devices for Conduit Occlusion

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0389959 A1
- Document ID: US20230389959A1
- Status: Published application
- Kind: A1
- Application number: 18/233,143
- Filed: 2023-08-11
- Published: 2023-12-07
- Earliest claimed: 2004-02-25
- Assignees: Femasys Inc.
- Applicants: Femasys Inc.
- Inventors: Kathy Lee-Sepsick; Lani L.L. Paxton; Jeffrey A. Marcus; Stephen N. Williams
- Web page: https://patentgrep.com/patent/US20230389959A1

## CPC

- A61B 17/42: Gynaecological or obstetrical instruments or methods {(ligaturing clamps or clips for the umbilical cord A61B17/122; curettage A61B17/320708)}
- A61B 17/12186: {liquid materials adapted to be injected}
- A61F 2/954: for placing stents or stent-grafts in a bifurcation
- A61F 6/225: {transcervical}
- A61M 25/01: Introducing, guiding, advancing, emplacing or holding catheters (A61M25/10 takes precedence)
- A61B 2017/1205: {Introduction devices}
- A61B 2017/4225: {Cervix uteri}
- A61B 2017/4233: {Operations on Fallopian tubes, e.g. sterilization (A61B2017/1125 takes precedence)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

The present invention comprises systems, methods and devices for the delivery of compositions for occluding or of means for opening conduits. The implantable occlusive material may be delivered pre-formed or in situ cured and, may be a resorbable material that supports tissue ingrowth that eventually replaces the material leaving little or no original material in place. The delivery system is positioned to allow for placement of the occlusive material into the body conduit. Use of delivery systems, methods and devices for re-opening an occluded body conduit are also included.

## Claims

### Claim 1

A method for occluding at least one conduit in a human or animal body, comprising,
a) providing a delivery system capable of delivering an effective amount of a composition comprising an occlusive material, wherein the delivery system comprises a delivery device comprising at least an introducer shaft for providing at least two catheters; two catheters, each comprising an end structure on a delivery end and attachment means on a proximal end, a composition comprising an occlusive material, and means for providing the composition comprising an occlusive material into and through the catheters;
b) delivering an effective amount of the composition comprising an occlusive material at or near the target site such that the material occludes the lumen of the conduit; and
c) occluding the conduit with the composition comprising an occlusive material within the lumen of the conduit.

### Claim 2 (depends on 1)

The method of claim 1, wherein two conduits are occluded without removal and re-introduction or substantial repositioning of the introducer shaft.

### Claim 3 (depends on 2)

The method of claim 2, wherein the two conduits are fallopian tubes of a mammal.

### Claim 4 (depends on 1)

The method of claim 1, further comprising, d) reopening the at least one conduit.

### Claim 5 (depends on 1)

The method of claim 1, wherein the composition comprising the occlusive material is mixed prior to delivery to the lumen.

### Claim 6 (depends on 1)

The method of claim 1, wherein the composition comprising an occlusive material comprises a liquid tissue adhesive and a solvated polymer, wherein the composition cures in situ.

### Claim 7 (depends on 1)

The method of claim 1 wherein the composition comprising the occlusive material is ultrasound visible.

### Claim 8 (depends on 7)

The method of claim 7, wherein the ultrasound visible material comprises microbubbles of air or gas or microparticles of a material that entrap air or gas.

### Claim 9 (depends on 6)

The method of claim 6, wherein the liquid tissue adhesive is cyanoacrylate, polyacrylic acids, polyethylene glycols, modified polyethylene glycols, thrombin, collagen, collagen-based adhesives, fibrin, fibrin glue compositions, gelatin-resorcinol-formaldehyde-glutaraldehyde (GRFG) glue, autologous blood in combination with collagen or thrombin, crosslinked albumin adhesives, modified glycosaminiglycans, poly(N-isopropylacrylamide)-based adhesives, alginates, or chitosan or gelatin, crosslinked with carbodiimide or genepin; and the solvated polymer is a resorbable polyester, including polylactide, polyglycolide, or polycaprolactone or copolymers of these materials, including poly(lactide-/glycolide) acid (PLGA) or poly(lactide-co-F-caprolactone) (PLCL).

### Claim 10 (depends on 6)

The method of claim 6, wherein the cured composition swells less than 20%.

### Claim 11 (depends on 6)

The method of claim 6, wherein the cured composition is about 20% to about 100% substantially resorbed in a range of about 30 to about 365 days.

### Claim 12 (depends on 11)

The method of claim 11, wherein the occlusion is maintained by tissue ingrowth.

### Claim 13 (depends on 1)

The method of claim 1, wherein the composition comprising an occlusive material comprises a liquid tissue adhesive and particles.

### Claim 14 (depends on 13)

The method of claim 13, wherein the particles are nano- or micro-particles comprising spheres of resorbable polymers.

### Claim 15 (depends on 13)

The method of claim 13, wherein the particles are from about 0.1 micrometer to about 1000 micrometers in diameter.

### Claim 16 (depends on 1)

The method of claim 1 wherein the occlusive material is viewable by ultrasound.

### Claim 17 (depends on 6)

The method of claim 6, wherein the composition further comprises tissue scarring agents, fibrosis agents, fertilization inhibitors, contraceptive agents, tissue growth promoters, hormones, polymerization inhibitors, polymerization stabilizers, emulsifying agents, echogenic agents, contrast agents, viscosity-modifying materials, plasticizers, colorants or combinations thereof.

### Claim 18 (depends on 13)

The method of claim 13, wherein the composition further comprises a curable carrier for the occlusive materials, a control release agent, tissue scarring agents, fibrosis agents, fertilization inhibitors, contraceptive agents, tissue growth promoters, hormones, polymerization inhibitors, polymerization stabilizers, emulsifying agents, echogenic agents, contrast agents, viscosity-modifying materials, plasticizers, colorants or combinations thereof.

### Claim 19

A method for contraception, comprising,
a) providing a delivery system capable of delivering an effective amount of a composition comprising an occlusive material, wherein the delivery system comprises a delivery device comprising at least an introducer shaft for providing at least two catheters; two dual lumen balloon catheters; a composition comprising an occlusive material and means for providing the composition comprising an occlusive material into and through the catheters;
b) delivering an effective amount of the composition comprising an occlusive material at or near the target location such that the material occludes the lumen of at least one fallopian tube; and
c) occluding the fallopian tube with the composition comprising an occlusive material within the lumen of the conduit.

### Claim 20

A contraceptive device, comprising, an introducer shaft for providing at least two catheters; two catheters, each comprising an end structure at the delivery end; a composition comprising an occlusive material, and means for providing the composition comprising an occlusive material into and through the catheters.

### Claim 21 (depends on 19)

The device of claim 19, wherein the end structure is a cup, nozzle, or a balloon.

### Claim 22 (depends on 19)

The device of claim 19, further comprising a delivery device stabilizer for holding the contraceptive device in place once positioned.

### Claim 23 (depends on 21)

The device of claim 21, wherein the delivery device stabilizer fits over or attaches to the cervix or fits into or expands within the cervix to hold the device in position.

### Claim 24

A method for opening at least one occluded conduit, comprising,
a) providing a delivery device comprising at least an introducer shaft for providing at least two catheters; two catheters, each comprising an end structure at the delivery end; and means for re-opening the conduit; and
b) re-opening the conduit.

### Claim 25 (depends on 1)

A method for opening at least one occluded conduit occluded by the method of claim 1, comprising
a) providing a delivery system comprising a delivery device capable of delivering a means of opening the conduit; and
b) opening the conduit.

### Claim 26 (depends on 25)

The method of claim 25, wherein the delivery system capable of delivering means of opening the conduit comprises a delivery device comprising at least an introducer shaft for providing at least two catheters; at least one catheter, comprising a stationary device at one end; means for holding the delivery system in place upon positioning; and means for opening the conduit.

### Claim 27 (depends on 24)

The method of claim 24, wherein the means for opening the conduit comprise device or members for providing shockwaves to shatter the occluding material, chemical means including solvents, biological means including enzymes, or mechanical means including stiff or cutting catheter ends to recanalize the lumen.

### Claim 28 (depends on 24)

The method of claim 24, further comprising c) maintaining the opening of the conduit by providing a stent within the lumen of the conduit.
